The press statement from UNAIDS, dated October 2, 2024, highlights Gilead's announcement regarding the breakthrough HIV medicine lenacapavir, offering sev...
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management.
You’ll also feel our high-impact global and local perspectives with cultural intelligence.